Ora Biomedical Competitors and Similar CompaniesClear all

Ora Biomedical's competitors and similar companies include BrightGene, Caplin Point Laboratories, UCB and AbbVie.

	Ora Biomedical Ora Biomedical is a pharmaceutical company that provides drug development services.	BrightGene BrightGene (博瑞生物医药) is a research-driven biopharmaceutical company that engages in the research, development, and manufacturing of medicines.	Caplin Point Laboratories Caplin Point Laboratories is a pharmaceutical company manufacturing a range of formulations.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
Founding Date	Founding Date 2022	Founding Date 2001	Founding Date 1990	Founding Date 1928	Founding Date 2013
Type	Type Private	Type Public	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Seattle, US HQ	Locations Suzhou Shi, CN HQ Taizhou Shi, CN	Locations Chennai, IN HQ Chennai, IN Gerugambakkam, IN Suthukeny, IN	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more
Employees	Employees 1157% increase	Employees 1,151	Employees 3,406	Employees 9,052	Employees 55,00010% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.8 b	Valuation ($) N/A	Valuation ($) 34.3 b	Valuation ($) 335 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) ¥1.2b (FY, 2025)	Revenue (est.) ₹21.9b (FY, 2026)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) $61.2b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods ¥601.6m (FY, 2025)	Cost of goods ₹8.7b (FY, 2026)	Cost of goods €1.4b (FY, 2025)	Cost of goods $18.2b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit ¥609m (FY, 2025)	Gross profit ₹14.4b (FY, 2026)	Gross profit €7.2b (FY, 2025)	Gross profit $43b (FY, 2025)
Net income	Net income N/A	Net income ¥37m (FY, 2025)	Net income ₹6.5b (FY, 2026)	Net income €1.6b (FY, 2025)	Net income $4.2b (FY, 2025)
Operating ⚠
Countries	Countries N/A	Countries N/A	Countries N/A	Countries 35 (FY, 2019)	Countries 70 (FY, 2022)
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 30.6m	Total funding raised N/A	Total funding raised $ 3.8b